However, after day 20, the RT + IgG treated group showed significant tumor growth, while the RT + HA PD-1 Ig treated group exhibited continued control of tumor growth extending to day 30 (the last day of observation) (Fig. 4B and C). The gene discussed is PDCD1; the disease is neoplasm.